Reuters logo
10 天前
BRIEF-Agios posts Q2 loss per share $1.78‍​
2017年8月8日 / 上午11点11分 / 10 天前

BRIEF-Agios posts Q2 loss per share $1.78‍​

Aug 8 (Reuters) - Agios Pharmaceuticals Inc

* Agios reports second quarter 2017 financial results

* Agios Pharmaceuticals Inc - ‍collaboration revenue was $11.3 million for quarter ended June 30, 2017, compared to $7.0 million for comparable period in 2016​

* Agios Pharmaceuticals Inc - ‍expects to submit an NDA (new drug application) to U.S. FDA for ivosidenib for IDH1M positive r/r AML by end of 2017​

* Agios Pharmaceuticals Inc - ‍expects to submit ind application for AG-270, development candidate targeting mtap-deleted tumors, by end of 2017​

* Agios Pharma - ‍expects cash, cash equivalents as of June 30, 2017, will enable company to fund its anticipated through at least end of 2019​

* Agios Pharmaceuticals Inc qtrly loss per share $1.78‍​

* Q2 earnings per share view $-1.56, revenue view $9.6 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below